(Q40415241)

20 September 2017

Tumor lysate and IL-18 loaded dendritic cells elicits Th1 response, tumor-specific CD8+ cytotoxic T cells in patients with malignant glioma (English)

1 reference

20 September 2017

1 reference

1

1 reference

20 September 2017

Junpei Honma

2

1 reference

20 September 2017

Naoto Tsuchiya

3

1 reference

20 September 2017

Naoki Yajima

4

1 reference

20 September 2017

Tsutomu Kobayashi

5

1 reference

20 September 2017

Ryuichi Tanaka

6

1 reference

20 September 2017

1 April 2005

1 reference

Journal of Neuro-Oncology

20 September 2017

1 reference

20 September 2017

72

1 reference

20 September 2017

2

1 reference

20 September 2017

107-113

1 reference

https://scigraph.springernature.com/pub.10.1007/s11060-004-3550-9

20 September 2017

0 references

cites work

Direct activation of human CD8+ cytotoxic T lymphocytes by interleukin-18.

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS11060-004-3550-9

Breast and ovarian cancer-specific cytotoxic T lymphocytes recognize the same HER2/neu-derived peptide

21 January 2018

1 reference

12 December 2020

Regression of tumors in mice vaccinated with professional antigen-presenting cells pulsed with tumor extracts

1 reference

12 December 2020

Treatment of intracranial gliomas with bone marrow-derived dendritic cells pulsed with tumor antigens

1 reference

12 December 2020

Dendritic cells pulsed with tumor extract-cationic liposome complex increase the induction of cytotoxic T lymphocytes in mouse brain tumor

1 reference

12 December 2020

Vaccination of malignant glioma patients with peptide-pulsed dendritic cells elicits systemic cytotoxicity and intracranial T-cell infiltration

1 reference

12 December 2020

Proliferating dendritic cell progenitors in human blood

1 reference

12 December 2020

A simple and reliable method for screening retroviral producer clones without selectable markers

1 reference

12 December 2020

Dendritic cell-based glioma immunotherapy (review).

1 reference

12 December 2020

Mass spectrometric identification of a naturally processed melanoma peptide recognized by CD8+ cytotoxic T lymphocytes

1 reference

12 December 2020

Results of a phase I clinical trial of vaccination of glioma patients with fusions of dendritic and glioma cells.

1 reference

12 December 2020

Vaccination with irradiated tumor cells engineered to secrete murine granulocyte-macrophage colony-stimulating factor stimulates potent, specific, and long-lasting anti-tumor immunity

1 reference

12 December 2020

Cytotoxic T cells directed to tumor antigens not expressed on normal melanocytes dominate HLA-A2.1-restricted immune repertoire to melanoma.

1 reference

12 December 2020

Specific T helper cell requirement for optimal induction of cytotoxic T lymphocytes against major histocompatibility complex class II negative tumors

1 reference

12 December 2020

Tumor mRNA-loaded dendritic cells elicit tumor-specific CD8(+) cytotoxic T cells in patients with malignant glioma

1 reference

12 December 2020

Subcutaneous vaccination with irradiated, cytokine-producing tumor cells stimulates CD8+ cell-mediated immunity against tumors located in the "immunologically privileged" central nervous system

1 reference

12 December 2020

HER2/neu-derived peptides are shared antigens among human non-small cell lung cancer and ovarian cancer

1 reference

12 December 2020

A dendritic cell vaccine induces protective immunity to intracranial growth of glioma.

1 reference

12 December 2020

Enhancement of antitumor immune response in glioma models in mice by genetically modified dendritic cells pulsed with Semliki forest virus-mediated complementary DNA.

1 reference

12 December 2020

The dendritic cell system and its role in immunogenicity

1 reference

12 December 2020

Gradual loss of T-helper 1 populations in spleen of mice during progressive tumor growth

1 reference

12 December 2020

Identification of a peptide recognized by five melanoma-specific human cytotoxic T cell lines.

1 reference

12 December 2020

In vivo antitumor effects of murine interferon-gamma-inducing factor/interleukin-18 in mice bearing syngeneic Meth A sarcoma malignant ascites

1 reference

12 December 2020

Dendritic cells pulsed with RNA are potent antigen-presenting cells in vitro and in vivo

1 reference

12 December 2020

Vaccination of recurrent glioma patients with tumour lysate-pulsed dendritic cells elicits immune responses: results of a clinical phase I/II trial

1 reference

12 December 2020

Dendritic cells as adjuvants for class I major histocompatibility complex-restricted antitumor immunity

1 reference

12 December 2020

Human TH1 and TH2 subsets: regulation of differentiation and role in protection and immunopathology

1 reference

12 December 2020

Therapy of murine tumors with tumor peptide-pulsed dendritic cells: dependence on T cells, B7 costimulation, and T helper cell 1-associated cytokines

1 reference

12 December 2020

Recombinant IL-12 administration induces tumor regression in association with IFN-gamma production

1 reference

12 December 2020

Bone marrow-derived dendritic cells pulsed with tumor homogenate induce immunity against syngeneic intracerebral glioma

1 reference

12 December 2020

10.1007/S11060-004-3550-9

Identifiers

DOI

1 reference

Dimensions Publication ID

20 September 2017

0 references

1 reference